Email Updates

You are here

Home

26 FEBRUARY 2021 VOLUME 23 ISSUE 8

Media Coverage

  • African Union Backs Call To Waive IP Rights on COVID-19 Drugs

    The African Union is backing calls for drugmakers to waive some intellectual property rights on COVID-19 medicines and vaccines to speed up their rollout to poor countries, the head of its disease control body said on Thursday.

    February 25, 2021
    General
    Reuters

  • Syringe Programs Key to Connecting Women With PrEP, Research Shows

    What is the best way to protect more women who use drugs from HIV treatment? Researchers examined one aspect this question with a pilot study in Philadelphia in which they gave participating women PrEP, the HIV prevention regimen. They found that partnering with an established syringe service program (SSP) was an effective strategy.

    February 25, 2021
    PrEP
    Filter

  • Biden's Straight-Talking CDC Director Has Long Used Data To Save Lives

    In early December, Dr. Katy Stephenson was watching TV with her family and scrolling through Twitter when she saw a tweet that made her shout. "I said 'Oh, my God!' " she recalls. "Super loud. My kids jumped up. My husband looked over. He said, 'What's wrong, what's wrong, is everything OK?' I was like, 'No, no, it's the opposite. It's amazing. This is amazing!' "

    February 24, 2021
    General
    NPR

  • Why White HIV Leadership Needs to Give Reins to Black Leaders

    Leisha McKinley-Beach has something to say about national leadership in the fight against HIV. And she should know—she’s been working to counter the epidemic for nearly 30 years. The epidemic, she says, won’t change until the makeup of its leadership changes.

    February 23, 2021
    General
    The BodyPro

  • Will We Ever Have a HIV Vaccine?

    Crises have a habit of accelerating history, including the pace of technological advancement. The COVID-19 pandemic is no exception. Vaccines were developed, safely but with unprecedented efficiency, less than a year after the WHO declared a global pandemic.

    February 23, 2021
    HIV Vaccine
    Vaccines Today

  • For Men Only: New Cape Metro Men’s Health Centre Empowers Boys and Men With One-Stop Shop for Wellness

    Data the world over suggest men are less likely than women to seek medical help and use health services. In South Africa, about a third of new HIV infections in 2019 were in men, while more than half of HIV-related deaths were among men.

    February 23, 2021
    General
    Daily Maverick

  • New Study Highlights Lack of Diversity and Inclusion in Vaccine Clinical Trials

    A team of scientific experts from across the US and Puerto Rico are advocating for increased diversity in vaccine trials after publishing a new report that highlights a decade’s worth of disparities. The new study, published in JAMA Network Open, found that among US-based vaccine clinical trials, people who are Black/African American, American Indian/Alaska Native, Hispanic/Latino and age 65 and older were the most underrepresented groups. Conversely, adult women were overrepresented.

    February 23, 2021
    HIV Vaccine
    POZ

  • Baltic Neighbour States Far Apart on HIV Prevention

    High rates of needle and syringe provision, HIV testing and antiretroviral treatment have greatly reduced new HIV infections in Estonia since 2000 – but in the neighbouring Baltic state of Latvia, HIV infections continue to rise. The two nations provide a stark contrast in how to tackle an HIV epidemic driven by injecting drug use.

    February 22, 2021
    General
    aidsmap

  • Injectable Long-Acting PrEP Is Safe, Highly Effective in Cisgender Women

    Injectable long-acting cabotegravir (CAB LA) has been proven safe and highly effective in preventing HIV infection among cisgender women, according to interim results from a major study announced in late January. The findings complement previously established strong results for cabotegravir-based injectable pre-exposure prophylaxis (PrEP) in cisgender men who have sex with men (MSM) and transgender women who have sex men, adding to evidence that injectable PrEP could ultimately have greater real-world efficacy than daily oral PrEP in many populations, thanks to better adherence.

    February 19, 2021
    PrEP
    The BodyPro

  • Treatment Trial for African Transgender Women and Men Who Have Sex With Men Shows Successful Scale-Up Is Possible

    A 12-month HIV treatment trial for transgender women and men who have sex with men in Kenya, Malawi and South Africa saw antiretroviral treatment (ART) and viral suppression rates more than double.

    February 19, 2021
    Treatment
    Avert

Published Research

Announcements